美国对中国牛磺酸产品337调查案例分析

Case study on responding to 337 investigation against Chinese taurine products

在美国对中国牛磺酸产品337调查中,商务部、地方商务主管部门、医保商会和涉案企业通力合作,充分发挥了“四体联动”工作机制作用,通过签署有约束力的协议进行联合应诉,及时开展了公共利益抗辩并启动了百日速审程序。由于应对及时有力,本案以申请人撤销申请,美国国际贸易委员会终止调查,中国涉案企业胜诉而快速结案。本案创造了中国企业应对美国337调查的多项记录,为中小企业联合以产业之力成功应诉美国337调查提供了范本。本案的应诉策略也为其他国有企业提供了实战经验,从战略和战术双重层面提供了系统性的指导,有利于中国企业在中美贸易摩擦频起的今天能够更加自信、积极、有效地应对337调查,保护自己以及中国优势产业的合法利益。

In respond to 337 investigation against Chinese taurine and its methods of production and processes,Chinese central and local commerce governments,industrial organizations and the Chinese companies involved in the case cooperated to give full play to the role of the"Four Body Linkage"Working Mechanism,jointly responded to the investigation by signing a binding agreement,promptly launched the public interest defense and initiated the 100-day quick trial procedure.Due to the timely and effective responses,the case quickly ended with the withdrawal of the application by the applicant and the termination of the investigation by ITC.The success of the Chinese companies involved in the case has created many records of Chinese companies responding to 337 investigations,and provided a model for SMEs to succeed in the investigation with the help of industrial organizations.The response strategy of this case also provided pragmatic experience for other Chinese enterprises,and provided systematic guidances from the strategic and tactical perspectives,which is conducive to Chinese enterprises to respond to the 337 investigations more confidently,actively and effectively so as to protect their legitimate interests and China’s advantageous industries.